# Buspirone as a Potential Treatment for Recurrent Central Apnea

> **NCT00746954** · PHASE3 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 8 (actual)

## Conditions studied

- Central Apnea
- Heart Failure

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Buspirone

## Key facts

- **NCT ID:** NCT00746954
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Patient recruitment and Funding inadequate to finish trial
- **Last updated:** 2016-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00746954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00746954, "Buspirone as a Potential Treatment for Recurrent Central Apnea". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00746954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*